4.4 Letter

Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia

Journal

HAEMATOLOGICA
Volume 104, Issue 4, Pages E138-E142

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2018.192807

Keywords

-

Categories

Funding

  1. Syros Pharmaceuticals, Inc.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available